Investigating the links between the APOE genotype, the gut microbiome, and plant-based polyphenols (360G-Wellcome-226858_Z_23_Z)
Aside from ageing, the most prevalent risk of Alzheimer’s disease (AD) is the apolipoprotein E (APOE) gene. The gene not only influences the brain but also the gut microbiome. The differing gut microbiome produces different gut metabolites. Dietary polyphenols have been shown to alter the gut microbiome and its metabolites. In this project, I will use the batch fermentation colon model of polyphenols using stool samples obtained from APOE genotyped participants to measure the changes during the polyphenol fermentation and metabolism. Polyphenols breakdown will be analysed using LCMS and NMR techniques. I am doing this with the aim of establishing whether the APOE genotype influences polyphenol metabolism and therefore the health benefit of these food bioactives. To account for shifting microbial populations, metagenomic analysis of the bacteria would be analysed to identify the initial differences between the gut microbiome of the differing genotypes. Then also how they change during the fermentation of the polyphenols. Finally, I will use a high throughput ageing model of APOE transgenic C. elegans to identify the mechanism of the metabolites on longevity. This will improve our understanding of the interaction between the APOE genotype, the metabolism of the gut microbiome and its links to AD.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.